MM

Madan Mohan Mondal

Active Director Director DIN 05280203
DIN 05280203 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Madan Mohan Mondal

Data last updated:

Madan Mohan Mondal is a Director at Helmon Pharmaceuticals And Chemicals Private Limited (since 2025). The company operates in Pharma.

DIN 05280203
Primary Designation Director
Industry Pharma
First Appointment 02 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Helmon Pharmaceuticals And Chemicals Private Limited
Premium access

Shareholding and investment profile for Madan Mohan Mondal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madan Mohan Mondal

Madan Mohan Mondal currently holds 1 directorship: Helmon Pharmaceuticals And Chemicals Private Limited (Director, since 02 Dec 2025).

Madan Mohan Mondal was first appointed on 02 Dec 2025 as Director at Helmon Pharmaceuticals And Chemicals Private Limited.

The current boards of Madan Mohan Mondal's companies include Ashis Samanta (Helmon Pharmaceuticals And Chemicals Private Limited), Biswanath Manna (Helmon Pharmaceuticals And Chemicals Private Limited), Debasis Manna (Helmon Pharmaceuticals And Chemicals Private Limited), Pulak Samanta (Helmon Pharmaceuticals And Chemicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available